Scientific Product - Search News

Penumbra, Boston Scientific

Boston Scientific to buy Penumbra for more than $14 billion

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots from veins and arteries.

· 1d · on MSN

Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots

· 1d · on MSN

Boston Scientific to buy Penumbra for $15 billion in cash, stock

· 1d

Boston Scientific announces agreement to acquire Penumbra, Inc.

· 1d

Boston Scientific to buy Penumbra in $14.5 billion deal

· 1d

Boston Scientific to acquire Penumbra for enterprise value of ~$14.5B

Seeking Alpha

Semler Scientific: Great Product Can Still Thrive Post Medicare Advantage

Semler Scientific's primary product, QuantaFlo, is a fast and easy-to-use device for diagnosing peripheral arterial disease. Its stock has dropped nearly 50% in value, presenting a potential opportunity for investors. Despite losing the support from ...

Business Wire

FUJIFILM Irvine Scientific Adds Key Products to Its Life Sciences Portfolio from FUJIFILM Wako Chemicals U.S.A.

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, today announced further expansion of its product portfolio and ...

PharmiWeb

Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 15, 2025 / Bioz, Inc., the leading AI-powered engine for scientific product insights, proudly announces the deployment of 1,000 Bioz Badges on Multi Sciences' English and Chinese product webpages.